ASPIRA PATHLAB & DIAGNOSTICS
|
The Current P/E Ratio of ASPIRA PATHLAB & DIAGNOSTICS is 52.75.
| Share Price | ₹131.0 | Nov 20,2026 |
| Market Cap | ₹134.9 Cr | |
| Earnings-TTM | ₹2.6 Cr | TTM-Consolidated Results |
| Price/Earnings | 52.75x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ASPIRA PATHLAB & DIAGNOSTICS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹134.9 Cr] as on Nov 20,2026
(/) Earnings [ ₹2.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 52.75x ]
Thus, for ASPIRA PATHLAB & DIAGNOSTICS , the investors are currently willing to pay 52.75 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ASPIRA PATHLAB & DIAGNOSTICS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ASPIRA PATHLAB & DIAGNOSTICS over the last five years.
Historical PE (Price/Earnings) ratio chart of ASPIRA PATHLAB & DIAGNOSTICS
PE Ratio Performance Analysis for ASPIRA PATHLAB & DIAGNOSTICS
- ASPIRA PATHLAB & DIAGNOSTICS 's p/e ratio for fiscal years ending Mar2025 to Mar2024 averaged 21.69x.
- ASPIRA PATHLAB & DIAGNOSTICS 's operated at median p/e ratio of 43.37x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, ASPIRA PATHLAB & DIAGNOSTICS 's p/e ratio peaked in Mar2025 at 43.37x.
- ASPIRA PATHLAB & DIAGNOSTICS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does ASPIRA PATHLAB & DIAGNOSTICS 's P/E Ratio benchmark against top 10 peers in Hospital & Healthcare Services Industry?
| Peer Comparison (Hospital & Healthcare Services Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ASPIRA PATHLAB & DIAGNOSTICS | 2.56 | 52.75 | 134.9 |
| APOLLO HOSPITALS ENTERPRISE LTD | 2,286.10 | 57.80 | 132,139.0 |
| MAX HEALTHCARE INSTITUTE LTD | 1,380.55 | 76.11 | 105,080.0 |
| FORTIS HEALTHCARE LTD | 1,041.67 | 59.79 | 62,284.1 |
| ASTER DM HEALTHCARE LTD | 597.56 | 113.73 | 67,959.9 |
| NARAYANA HRUDAYALAYA LTD | 872.71 | 45.56 | 39,757.4 |
| GLOBAL HEALTH LTD | 613.08 | 64.96 | 39,828.8 |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | 193.80 | 172.77 | 33,482.9 |
| DR LAL PATHLABS LTD | 588.10 | 57.27 | 33,679.7 |
| DR AGARWALS HEALTH CARE LTD | 205.46 | 89.57 | 18,402.2 |
| RAINBOW CHILDRENS MEDICARE LTD | 298.55 | 42.86 | 12,795.4 |
Hospital & Healthcare Services Industry Benchmark (Top 10) PE Analysis vs ASPIRA PATHLAB & DIAGNOSTICS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 42.86x |
| Max industry PE | 172.77x |
| Median industry PE | 59.79x |
| Average industry PE | 75.74x |
You may also like the below Video Courses